Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...

Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...

Capital World Investors (Trades, Portfolio) executed a significant transaction by reducing their holdings in Tandem Diabetes ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Tandem ...

Check the time stamp on this data. Updated AI-Generated Signals for Tandem Diabetes Care Inc. (TNDM) available here: TNDM.

An investigational once-weekly insulin was noninferior to a daily option for patients with type 2 diabetes, but proved risky ...

Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...